Linked Life Data

1315592

Source:http://linkedlifedata.com/resource/pubmed/id/1315592

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1992-6-8
pubmed:abstractText
Percutaneous ethanol injection (PEI) under ultrasound control is a new therapeutic procedure for cirrhotic patients with small hepatocellular carcinoma (HCC). Our experience included 70 patients with 110 lesions (range 0.8-5 cm). Follow-up ranged from 5 to 70 months (mean: 25 months). No serious complications occurred after 930 treatments. The 1, 2, 3-year survival rates (Kaplan-Meier method) were: 96, 84, 72% for single lesions less than 5 cm and 94, 84, 25% for multiple lesions. In our opinion and in consideration of the results of other authors obtained with PEI and with surgery, single lesions less than 5 cm found in Child's A and B patients with high surgical risk or with some adverse prognostic factors for surgery, could be an indication for PEI.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0392-0623
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
72-4
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Percutaneous ethanol injection of hepatocellular carcinoma: survival after 3 years in 70 patients.
pubmed:affiliation
Ospedale Civile, Vimercate, Milano, Italy.
pubmed:publicationType
Journal Article, Clinical Trial